• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球儿童艾滋病毒预防、护理和治疗服务:来自艾滋病流行病学数据库联盟(IeDEA 联盟)的一项横断面调查。

Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium.

机构信息

Department of Global Health and Health System Design, Icahn School of Medicine at Mount Sinai Arnhold Institute for Global Health, New York, New York, USA

Department of Biostatistics and Health Data Science, Indiana University Richard M Fairbanks School of Public Health, Indianapolis, Indiana, USA.

出版信息

BMJ Open. 2023 Mar 13;13(3):e069399. doi: 10.1136/bmjopen-2022-069399.

DOI:10.1136/bmjopen-2022-069399
PMID:36914183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10016275/
Abstract

OBJECTIVES

To assess access children with HIV have to comprehensive HIV care services, to longitudinally evaluate the implementation and scale-up of services, and to use site services and clinical cohort data to explore whether access to these services influences retention in care.

METHODS

A cross-sectional standardised survey was completed in 2014-2015 by sites providing paediatric HIV care across regions of the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. We developed a comprehensiveness score based on the WHO's nine categories of essential services to categorise sites as 'low' (0-5), 'medium', (6-7) or 'high' (8-9). When available, comprehensiveness scores were compared with scores from a 2009 survey. We used patient-level data with site services to investigate the relationship between the comprehensiveness of services and retention.

RESULTS

Survey data from 174 IeDEA sites in 32 countries were analysed. Of the WHO essential services, sites were most likely to offer antiretroviral therapy (ART) provision and counselling (n=173; 99%), co-trimoxazole prophylaxis (168; 97%), prevention of perinatal transmission services (167; 96%), outreach for patient engagement and follow-up (166; 95%), CD4 cell count testing (126; 88%), tuberculosis screening (151; 87%) and select immunisation services (126; 72%). Sites were less likely to offer nutrition/food support (97; 56%), viral load testing (99; 69%) and HIV counselling and testing (69; 40%). 10% of sites rated 'low', 59% 'medium' and 31% 'high' in the comprehensiveness score. The mean comprehensiveness of services score increased significantly from 5.6 in 2009 to 7.3 in 2014 (p<0.001; n=30). Patient-level analysis of lost to follow-up after ART initiation estimated the hazard was highest in sites rated 'low' and lowest in sites rated 'high'.

CONCLUSION

This global assessment suggests the potential care impact of scaling-up and sustaining comprehensive paediatric HIV services. Meeting recommendations for comprehensive HIV services should remain a global priority.

摘要

目的

评估感染艾滋病毒的儿童获得综合艾滋病毒护理服务的情况,对服务的实施和扩大进行纵向评估,并利用现场服务和临床队列数据来探讨获得这些服务是否会影响患者的治疗保留率。

方法

2014 年至 2015 年,在国际艾滋病流行病学数据资料库以评价艾滋病(IeDEA)联合会的各区域,通过提供儿科艾滋病毒护理的各个站点进行了一项横断面标准化调查。我们根据世界卫生组织(WHO)的九项基本服务类别制定了一项综合评分,将站点分为“低”(0-5)、“中”(6-7)或“高”(8-9)。当可用时,将综合评分与 2009 年调查的评分进行比较。我们使用具有站点服务的患者水平数据来研究服务的综合性与保留之间的关系。

结果

对来自 32 个国家的 174 个 IeDEA 站点的调查数据进行了分析。在世界卫生组织的基本服务中,站点最有可能提供抗逆转录病毒治疗(ART)供应和咨询(n=173;99%)、复方磺胺甲噁唑预防(168;97%)、预防围产期传播服务(167;96%)、患者参与和随访的外展服务(166;95%)、CD4 细胞计数检测(126;88%)、结核病筛查(151;87%)和选择免疫接种服务(126;72%)。站点不太可能提供营养/食物支持(97;56%)、病毒载量检测(99;69%)和艾滋病毒咨询和检测(69;40%)。10%的站点评分为“低”,59%的站点评分为“中”,31%的站点评分为“高”。服务综合评分从 2009 年的 5.6 显著增加到 2014 年的 7.3(p<0.001;n=30)。在启动抗逆转录病毒治疗后,从治疗中丢失的患者的风险分析估计,评分“低”的站点风险最高,评分“高”的站点风险最低。

结论

这项全球评估表明,扩大和维持全面的儿科艾滋病毒护理服务具有潜在的护理影响。满足全面艾滋病毒服务的建议应继续成为全球优先事项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c3/10016275/fa01f529a845/bmjopen-2022-069399f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c3/10016275/37536e9a37d2/bmjopen-2022-069399f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c3/10016275/fa01f529a845/bmjopen-2022-069399f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c3/10016275/37536e9a37d2/bmjopen-2022-069399f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c3/10016275/fa01f529a845/bmjopen-2022-069399f02.jpg

相似文献

1
Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium.全球儿童艾滋病毒预防、护理和治疗服务:来自艾滋病流行病学数据库联盟(IeDEA 联盟)的一项横断面调查。
BMJ Open. 2023 Mar 13;13(3):e069399. doi: 10.1136/bmjopen-2022-069399.
2
Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016.国际艾滋病流行病学数据库评估艾滋病全球艾滋病毒队列合作组织,2000-2016 年,成人艾滋病毒感染者个体临床保留与关怀的地点层面综合性相关。
AIDS Patient Care STDS. 2022 Sep;36(9):343-355. doi: 10.1089/apc.2022.0042. Epub 2022 Aug 26.
3
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.3岁以下HIV感染儿童抗逆转录病毒疗法的优化
Cochrane Database Syst Rev. 2014 May 22;2014(5):CD004772. doi: 10.1002/14651858.CD004772.pub4.
4
Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.抗逆转录病毒疗法对2岁以下感染艾滋病毒儿童的疗效。
Cochrane Database Syst Rev. 2012 Jul 11(7):CD004772. doi: 10.1002/14651858.CD004772.pub3.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration.抗逆转录病毒治疗的儿童全球艾滋病毒死亡率趋势,对漏报死亡进行校正:国际艾滋病流行病学数据库合作的最新分析。
J Int AIDS Soc. 2021 Sep;24 Suppl 5(Suppl 5):e25780. doi: 10.1002/jia2.25780.
7
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
8
Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.全球艾滋病毒诊所参与国际艾滋病流行病学数据库评估研究联盟(IeDEA)的全球站点评估调查的设计与实施。
PLoS One. 2023 Mar 14;18(3):e0268167. doi: 10.1371/journal.pone.0268167. eCollection 2023.
9
Contributory factors to partial implementation of prevention of mother to child transmission policy in South Africa.南非预防母婴传播政策部分实施的促成因素。
BMC Pregnancy Childbirth. 2025 Jul 28;25(1):792. doi: 10.1186/s12884-025-07909-1.
10
Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.在资源匮乏地区,针对感染艾滋病毒的成人和青少年治疗失败时何时更换一线抗逆转录病毒治疗方案的最佳监测策略。
Cochrane Database Syst Rev. 2010 Apr 14(4):CD008494. doi: 10.1002/14651858.CD008494.

引用本文的文献

1
Characterizing adolescent and youth-friendly HIV services: a cross-sectional assessment across 16 global sites.描述青少年友好型和青年友好型艾滋病病毒服务:一项针对16个全球地点的横断面评估。
J Int AIDS Soc. 2025 Apr;28(4):e26437. doi: 10.1002/jia2.26437.
2
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study.撒哈拉以南非洲地区 HIV 感染儿童和青少年开始抗逆转录病毒治疗后 1 年内死亡率预测:一项回顾性观察队列研究。
Lancet Glob Health. 2024 Jun;12(6):e929-e937. doi: 10.1016/S2214-109X(24)00091-3.

本文引用的文献

1
Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.在儿科 IeDEA 全球队列联盟中,在启动抗逆转录病毒治疗之前和之后,对 0 至 24 岁患有围产期获得性 HIV 的儿童、青少年和年轻人,按年龄和 CD4 分层的死亡率和世界卫生组织 3 期和 4 期事件的时变率。
J Int AIDS Soc. 2020 Oct;23(10):e25617. doi: 10.1002/jia2.25617.
2
Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort.抗逆转录病毒治疗启动后 5 年内感染 HIV 的儿童在 IeDEA 西非儿科队列中的生长情况。
Trop Med Int Health. 2019 Jun;24(6):775-785. doi: 10.1111/tmi.13237. Epub 2019 Apr 15.
3
HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.接受抗逆转录病毒治疗的成人和儿童的HIV病毒载量抑制——来自IeDEA合作项目的结果
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):319-329. doi: 10.1097/QAI.0000000000001499.
4
Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.儿科治疗扩大规模:全球计划未完成的议程。
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S59-S65. doi: 10.1097/QAI.0000000000001333.
5
Scale-up of Early Infant HIV Diagnosis and Improving Access to Pediatric HIV Care in Global Plan Countries: Past and Future Perspectives.扩大全球计划国家的早期婴儿艾滋病毒诊断及改善儿童艾滋病毒治疗可及性:过去与未来展望
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S51-S58. doi: 10.1097/QAI.0000000000001319.
6
Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.国际流行病学数据库与评估协作组(IeDEA)全球艾滋病治疗点提供的艾滋病护理服务的全面性:2009年与2014年。
J Int AIDS Soc. 2017 Jan 6;20(1):20933. doi: 10.7448/IAS.20.1.20933.
7
Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.利用频谱艾滋病影响模型改进对感染艾滋病毒儿童数量的估计。
AIDS. 2017 Apr;31 Suppl 1(Suppl 1):S13-S22. doi: 10.1097/QAD.0000000000001306.
8
Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview.抗逆转录病毒治疗环节中儿童的衔接、启动和维持:概述。
AIDS. 2013 Nov;27 Suppl 2(0 2):S207-13. doi: 10.1097/QAD.0000000000000095.
9
Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.中低收入国家抗逆转录病毒治疗项目中的结核病:诊断和筛查工具的可及性和使用情况。
PLoS One. 2013 Oct 17;8(10):e77697. doi: 10.1371/journal.pone.0077697. eCollection 2013.
10
A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa--the International epidemiologic Databases to Evaluate AIDS (IeDEA).亚洲和撒哈拉以南非洲儿科艾滋病毒规划和临床管理做法调查--国际艾滋病流行病学数据库评估(IeDEA)。
J Int AIDS Soc. 2013 Jan 15;16(1):17998. doi: 10.7448/IAS.16.1.17998.